93 related articles for article (PubMed ID: 15550936)
1. The post-translational phosphorylation and acetylation modification profile is not the determining factor in targeting endogenous stress-induced p53 to mitochondria.
Nemajerova A; Erster S; Moll UM
Cell Death Differ; 2005 Feb; 12(2):197-200. PubMed ID: 15550936
[No Abstract] [Full Text] [Related]
2. Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein.
Kao CF; Chen SY; Chen JY; Wu Lee YH
Oncogene; 2004 Apr; 23(14):2472-83. PubMed ID: 14968111
[TBL] [Abstract][Full Text] [Related]
3. Methylation-acetylation interplay activates p53 in response to DNA damage.
Ivanov GS; Ivanova T; Kurash J; Ivanov A; Chuikov S; Gizatullin F; Herrera-Medina EM; Rauscher F; Reinberg D; Barlev NA
Mol Cell Biol; 2007 Oct; 27(19):6756-69. PubMed ID: 17646389
[TBL] [Abstract][Full Text] [Related]
4. Regulation of p53 responses by post-translational modifications.
Xu Y
Cell Death Differ; 2003 Apr; 10(4):400-3. PubMed ID: 12719715
[No Abstract] [Full Text] [Related]
5. Induction of ser15 and lys382 modifications of p53 by blockage of transcription elongation.
Ljungman M; O'Hagan HM; Paulsen MT
Oncogene; 2001 Sep; 20(42):5964-71. PubMed ID: 11593403
[TBL] [Abstract][Full Text] [Related]
6. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses.
Jimenez GS; Khan SH; Stommel JM; Wahl GM
Oncogene; 1999 Dec; 18(53):7656-65. PubMed ID: 10618705
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between site-specific modifications on p53 and histone H3.
Warnock LJ; Adamson R; Lynch CJ; Milner J
Oncogene; 2008 Mar; 27(11):1639-44. PubMed ID: 17891183
[TBL] [Abstract][Full Text] [Related]
8. p53 and Bad: remote strangers become close friends.
Jiang P; Du W; Wu M
Cell Res; 2007 Apr; 17(4):283-5. PubMed ID: 17404594
[No Abstract] [Full Text] [Related]
9. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
10. p53 stabilization can be uncoupled from its role in transcriptional activation by loss of PTTG1/securin.
Bernal JA; Hernández A
J Biochem; 2007 May; 141(5):737-45. PubMed ID: 17383977
[TBL] [Abstract][Full Text] [Related]
11. Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress.
Brandl A; Wagner T; Uhlig KM; Knauer SK; Stauber RH; Melchior F; Schneider G; Heinzel T; Krämer OH
J Mol Cell Biol; 2012 Oct; 4(5):284-93. PubMed ID: 22493095
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor.
Kuo PC; Tsao YP; Chang HW; Chen PH; Huang CW; Lin ST; Weng YT; Tsai TC; Shieh SY; Chen SL
Cancer Res; 2009 Dec; 69(23):8877-85. PubMed ID: 19903847
[TBL] [Abstract][Full Text] [Related]
13. Role of phosphorylation in p53 acetylation and PAb421 epitope recognition in baculoviral and mammalian expressed proteins.
Warnock LJ; Raines SA; Mee TR; Milner J
FEBS J; 2005 Apr; 272(7):1669-75. PubMed ID: 15794754
[TBL] [Abstract][Full Text] [Related]
14. Lysine acetylation targets protein complexes and co-regulates major cellular functions.
Choudhary C; Kumar C; Gnad F; Nielsen ML; Rehman M; Walther TC; Olsen JV; Mann M
Science; 2009 Aug; 325(5942):834-40. PubMed ID: 19608861
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
16. TAT-RasGAP317-326 requires p53 and PUMA to sensitize tumor cells to genotoxins.
Michod D; Widmann C
Mol Cancer Res; 2007 May; 5(5):497-507. PubMed ID: 17510315
[TBL] [Abstract][Full Text] [Related]
17. Benzo(a)pyrene increases phosphorylation of p53 at serine 392 in relation to p53 induction and cell death in MCF-7 cells.
Tampio M; Loikkanen J; Myllynen P; Mertanen A; Vähäkangas KH
Toxicol Lett; 2008 May; 178(3):152-9. PubMed ID: 18440733
[TBL] [Abstract][Full Text] [Related]
18. The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines.
Blanco S; Klimcakova L; Vega FM; Lazo PA
FEBS J; 2006 Jun; 273(11):2487-504. PubMed ID: 16704422
[TBL] [Abstract][Full Text] [Related]
19. Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53.
van Dieck J; Teufel DP; Jaulent AM; Fernandez-Fernandez MR; Rutherford TJ; Wyslouch-Cieszynska A; Fersht AR
J Mol Biol; 2009 Dec; 394(5):922-30. PubMed ID: 19819244
[TBL] [Abstract][Full Text] [Related]
20. Skp2 suppresses p53-dependent apoptosis by inhibiting p300.
Kitagawa M; Lee SH; McCormick F
Mol Cell; 2008 Feb; 29(2):217-31. PubMed ID: 18243116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
